PapGene, Inc.
BiotechnologyMaryland, United States11-50 Employees
PapGene, Inc. is a biotechnology company based in Baltimore, Maryland, focusing on developing cancer diagnostics with the aim of improving human health. Its core platform centers on detecting genetic mutations in cells collected from body fluids to enable early cancer detection, supported by advanced genetic sequencing and proprietary bioinformatics software. The company targets the oncology diagnostics market, aiming to provide tests that can monitor and surveil cancer through noninvasive means, particularly using urine-based approaches for bladder cancer as part of its development efforts. Established in the biotechnology research sector, PapGene positions itself within a field that combines molecular genetics with diagnostic testing to address early detection and disease management. The organization operates with a team size typical of a specialty biotech startup and has pursued recognition within regional innovation communities, reflecting its role in advancing diagnostic tools for cancer surveillance. A notable recent development includes ongoing progress toward commercializing its genetic cytology-based tests for cancer detection, highlighting its focus on translating research into clinically applicable diagnostics.
1-888-653-2347 
support@leadiq.com 
